InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Curtis Eric, 首席执行官. Officer active across 1 company, notably Windtree Therapeutics INC. Aggregated, 3 filings have been logged. Activity tracked since 4 March 2022. The latest transaction was disclosed on 23 August 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Eric Curtis is the Chief Operating Officer and Senior Vice President at Windtree Therapeutics Inc. He oversees the company's operations, ensuring efficiency and process optimization. With experience in the biopharmaceutical sector, Curtis contributes to the company's growth and innovation.